A global partnership to accelerate the fight against HIV/AIDS

CREATING A FAST LANE FOR CHANGE

New interventions and technologies in the fight against HIV/AIDS

In the fight against HIV/AIDS hundreds of simple, innovative, high-impact ideas are conceived of every day. Yet

a dearth of funds means

young people are

many of these lifesaving interventions never have the chance to fully develop.

infected with HIV each year. The UNICEF HIV/AIDS Innovation Fund seeks to help change this. By harnessing the greatest minds and investing in interventions and technologies
As a result, with the highest potential to break through bottlenecks and achieve scale the Fund will help realize an

1.26 million

HIV-free generation

by 2015. Join us in the next phase of the fight against HIV/AIDS.

MOVING TOWARD AN HIV-FREE GENERATION

1.26 million children and young people are newly infected with HIV each year. By 2015, the global community aims to reduce this number by 50%.

To do this UNICEF and partners will:

Reduce new infant infection by 90% Reduce new youth infection by 30%

From 370,000 to 37,000

From 890,000 to 623,000
Each figure represents 10,000 children newly infected each year.

STAGING INNOVATIONS FOR SCALE-UP

The UNICEF HIV/AIDS Innovation Fund brings together top HIV experts with diverse business and philanthropic leaders to invest in high-impact, low-cost interventions and technologies that have the potential to help us realize an HIV-free generation.

How it works:
Working in more than 150 developing countries, UNICEF draws from a vast network of partners to source the most innovative ideas that address unmet needs and service hard-to reach populations. The Fund incubates these ideas, providing financing and expertise through the pilot phase. UNICEF works with governments, NGOs, academia, and multilateral partners to stage the most successful projects for scale, breaking bottlenecks, boosting capacity, and encouraging new commitments.

1
Projects with the highest potential are recommended for seed funding by the Advisory Committee.

Funders and partners receive narrative and financial reports, helping them to monitor investments and continually align funding with the

most effective innovations.

KEY ELEMENTS OF THE INNOVATION FUND

Rapid, flexible resources building a pathway to scale

Pooled

fund of $5 million/year. metrics for

Transparent criteria and process for selection of projects, including defined

measuring success/impact.

Provision of rapid, flexible resources during the early stages of a projects life cycle, building a pathway to scale-up by governments and donors. Advisory Committee comprised of HIV experts and lead to recommend the highest-potential projects for seed funding. External/private sector expertise leveraged to strengthen Five year initial

funders working together

projects as needed.

phase from 2011 to 2015, with annual review of results and impact.

INNOVATION FUND TARGET AREAS FOR INVESTMENT

Investing for impact

Solutions for Last Mile Delivery Strengthen drug and local supply chains Ensure drug delivery and uptake by hardest-to-reach populations Facilitate improved disease reporting, test result delivery, and treatment monitoring Develop open-source mobile technology for integrated health services

Innovation in the Youth Agenda Reimagine youth-friendly HIV/AIDS prevention and treatment platforms Empower youth through technology, social networks, and other new media Enable peer-to-peer communication and support to reduce stigma Strengthening Families and Communities Build social and economic systems that incentivize well-being and facilitate access to health care for the hardest-to-reach Design resources for community-based health care and education Optimizing Management Systems Maximize cost effectiveness of interventions and outcomes Improve data use and management

INNOVATION FUND PROJECT SELECTION CRITERIA

Breaking through bottlenecks, delivering results, positioning for scale-up

Focus on new interventions and technologies, or innovations to current approaches that contribute to reducing the impact of HIV/AIDS on women and children. IIdentify specific the HIV/AIDS landscape.

bottlenecks to be addressed and show how a project can help change results within 23 years. and funding

Be evidence-based and contribute on-the-ground

Demonstrate how proof-of-concept could lead to scale-up by governments and donors. lBuild

on partnerships on the ground, link with national oversight. projects success.

Use existing global and national data and indicators to measure lBe

fundable with approximately $500K per project.

INNOVATION: RAPID SMS MOBILE TECHNOLOGY

RapidSMS improves access to HIV test results and services for women and infants

Problem

Transportation barriers and logistical challenges lead to slow reporting of HIV test results, delaying early infant diagnosis and inhibiting treatment for mothers and infants.

1
Baby born to HIV+ mother
Sample Blood Dried (DBS)

All pregnant mothers are offered testing

Blood sample taken at local clinic

Dried Dried Blood Dried Blood Samp Blood Samp le Samp le (DBS (DBS le (DBS ) ) )

CLINIC

Solution Results

3
Samples packed and logged

Use of RapidSMS phone technology to drastically reduce wait time for results. 50% improvement in the delivery of HIV results for infants. Helps ensure treatment availability and adherence. Speed Wait time for test results cut from months to days. Cost No SMS cost for clinic staff. Scale Potential for national scale at low cost. Reporting Web portal provides national view of HIV rates and treatment.
Results received by clinic worker and logged

SMS sent to hub clinic to conrm transport of samples

Dried Dried Blood Dried Blood Samp Blood Samp le Samp le (DBS (DBS le (DBS ) ) )

6
HUB CLINIC

Samples transported to district hub clinic

SMS

7 Hub clinic receives

and logs samples

Results processed and sent to clinic via SMS

10

8
Lab receives samples
Dried Bloo Dried Bloo Dried Bloo d Sam Dried Bloo Sam ple (DBS Dried Bloo d d d Sample (DBS Sam ple Blood d Sam ple (DBS ) ) Sample (DBS ) ple (DBS) (DBS) ) Dried

Hub aggregates samples and sends to lab

Benefits

LAB

11
Mother retrieves blood test results from clinic and results are logged

Mother is contacted

12

13

14

If HIV+, child starts treatment. If negative, child retested in six months

OPPORTUNITY

UNICEF as a Partner for Innovation

UNICEF is present in more than 150 developing countries, and has a long history of identifying and scaling innovative solutions for children. We are looking for partners who share our belief that the next step in the fight against HIV/AIDS calls for new collaboration models and a willingness to embrace innovation.

GBCHealth as Co-Sponsor
GBCHealth is a global leader dedicated to business leadership and cross-sector collective action to overcome the major public health challenges of our time. GBCHealth works with over 200 global companies who are united in their desire to improve global health.

Become a Seed Funder

Make a substantial, multi-year contribution to help seed the Fund. Join the Funds Advisory Committee a multi-disciplinary group of corporate and philanthropic leaders and top HIV experts and leverage your network to engage other funders and partners.

CONTACT US
For more information, please contact:

Rajesh Anandan Senior Vice President Private Sector Partnerships | UNICEF Ventures U. S. Fund for UNICEF (212) 992-2646 ranandan@unicefusa.org Colleen Galbraith Manager, Corporate Partnerships U. S. Fund for UNICEF (212) 922-2635 cgalbraith@unicefusa.org